正海生物
(300653)
| 流通市值：27.38亿 | | | 总市值：27.38亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 159,772,264.59 | 81,028,747.68 | 364,138,509.83 | 275,718,204.42 |
| 营业总成本 | 130,212,995.87 | 67,086,219.15 | 290,742,077.78 | 212,425,741.37 |
| 其他经营收益 | | | | |
| 营业利润 | 36,697,077.42 | 17,185,860.38 | 89,226,878.35 | 73,181,613.28 |
| 利润总额 | 36,749,302.64 | 17,200,846.2 | 88,125,650.76 | 73,182,503.36 |
| 净利润 | 33,306,086.87 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 33,306,086.87 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 721,677,902.99 | 749,500,201.54 | 733,392,006.91 | 712,175,260.87 |
| 非流动资产: | | | | |
| 非流动资产合计 | 248,044,421.04 | 253,390,200.36 | 251,227,448.93 | 252,676,881.61 |
| 资产总计 | 969,722,324.03 | 1,002,890,401.9 | 984,619,455.84 | 964,852,142.48 |
| 流动负债: | | | | |
| 流动负债合计 | 86,132,137.37 | 89,018,013.3 | 85,242,133.99 | 80,100,170.47 |
| 非流动负债: | | | | |
| 非流动负债合计 | 10,543,399.35 | 9,643,233.64 | 9,897,435.41 | 10,280,021.43 |
| 负债合计 | 96,675,536.72 | 98,661,246.94 | 95,139,569.4 | 90,380,191.9 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 873,046,787.31 | 904,229,154.96 | 889,479,886.44 | 874,471,950.58 |
| 股东权益合计 | 873,046,787.31 | 904,229,154.96 | 889,479,886.44 | 874,471,950.58 |
| 负债和股东权益合计 | 969,722,324.03 | 1,002,890,401.9 | 984,619,455.84 | 964,852,142.48 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 195,177,376.57 | 97,855,846.51 | 442,272,417.48 | 327,392,738.02 |
| 经营活动现金流出小计 | 166,885,812.82 | 85,077,617.1 | 345,081,741.74 | 253,195,707.2 |
| 经营活动产生的现金流量净额 | 28,291,563.75 | 12,778,229.41 | 97,190,675.74 | 74,197,030.82 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 556,178,660.49 | 354,108,609.38 | 1,023,931,504.3 | 769,595,327.66 |
| 投资活动现金流出小计 | 529,940,019.61 | 377,186,000.61 | 1,089,099,705.67 | 806,270,913.15 |
| 投资活动产生的现金流量净额 | 26,238,640.88 | -23,077,391.23 | -65,168,201.37 | -36,675,585.49 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 49,739,186 | - | 81,714,377 | 81,714,377 |
| 筹资活动产生的现金流量净额 | -49,739,186 | - | -81,714,377 | -81,714,377 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 4,791,018.63 | -10,299,161.82 | -49,691,902.63 | -44,192,931.67 |
| 期末现金及现金等价物余额 | 66,778,543.99 | 51,688,363.54 | 61,987,525.36 | 67,486,496.32 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 4,791,018.63 | - | -49,691,902.63 | - |